GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lowell Farms Inc (OTCPK:LOWLF) » Definitions » Debt-to-EBITDA

Lowell Farms (Lowell Farms) Debt-to-EBITDA : -0.39 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Lowell Farms Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Lowell Farms's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.99 Mil. Lowell Farms's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $17.52 Mil. Lowell Farms's annualized EBITDA for the quarter that ended in Dec. 2023 was $-50.64 Mil. Lowell Farms's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.39.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Lowell Farms's Debt-to-EBITDA or its related term are showing as below:

LOWLF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -6.06   Med: -1.67   Max: -0.08
Current: -0.69

During the past 13 years, the highest Debt-to-EBITDA Ratio of Lowell Farms was -0.08. The lowest was -6.06. And the median was -1.67.

LOWLF's Debt-to-EBITDA is ranked worse than
100% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs LOWLF: -0.69

Lowell Farms Debt-to-EBITDA Historical Data

The historical data trend for Lowell Farms's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lowell Farms Debt-to-EBITDA Chart

Lowell Farms Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.81 -3.74 -3.79 -6.06 -0.69

Lowell Farms Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.17 -13.76 7.93 -1.20 -0.39

Competitive Comparison of Lowell Farms's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Lowell Farms's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lowell Farms's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lowell Farms's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lowell Farms's Debt-to-EBITDA falls into.



Lowell Farms Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Lowell Farms's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.993 + 17.522) / -28.227
=-0.69

Lowell Farms's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.993 + 17.522) / -50.636
=-0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Lowell Farms  (OTCPK:LOWLF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Lowell Farms Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lowell Farms's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Lowell Farms (Lowell Farms) Business Description

Traded in Other Exchanges
Address
19 Quail Run Circle, Suite B, Salinas, CA, USA, 93907
Lowell Farms Inc is a California-based vertically-integrated cannabis company with advanced production capabilities supporting every step of the supply chain, including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. The Company's operations are comprised of a single reporting operating segment. Its Brands include Lowell Herb Co. and Lowell Smokes, House Weed, Kaizen, Moon, and Original Pot Company. The company generates revenues from sales of extracts, distillates, branded and packaged cannabis flower, pre­rolls, concentrates, and edible products to retail licensed dispensaries and bulk flower, biomass and concentrates to licensed manufacturers and distributors in the state of California.